Research Links Change in Brain with Addiction

February 1, 2007

A researcher at the University at Buffalo's Research Institute on Addictions (RIA) has found a change in the brain that occurs after drug use and that may contribute to drug addiction.

The finding, reported in the January 2007 issue of the journal Biological Psychiatry, demonstrates that repeated exposure to different types of drugs of abuse such as cocaine, nicotine, amphetamine, and alcohol lead to a persistent or long-term reduction in the electrical activity of dopamine neurons in the brain.

Dopamine neurons are the origin of the reward pathway responsible for the "feel good" experience that is such a strong component of drug use and abuse.

"A persistent reduction in dopamine neuron electrical activity after repeated exposure to different types of drugs appears to be the result of excessive excitation of dopamine neurons," according to Roh-Yu Shen, Ph.D., a neuroscientist and the lead investigator on the study. "This represents a new and potentially critical neural mechanism for addiction and provides a working model that suggests how the reward pathway function is altered and how these changes can be responsible for triggering intense craving and compulsive drug-seeking."

Initial exposure to drugs of abuse causes dopamine neurons to release dopamine in target areas of the brain that provide the reward effect of using drugs. Repeated abuse of drugs results in long-lasting changes in the function of the reward pathway that leads to craving for drugs and the compulsion for more drugs.

Shen is a senior research scientist at RIA and holds adjunct appointments in the Department of Pathology and Anatomical Sciences in the UB School of Medicine and Biomedical Sciences and Department of Psychology in the UB College of Arts and Sciences. Her colleagues on this study include Kar-Chan Choong, RIA research assistant, who performed the experiments, and Alexis C. Thompson, Ph.D., RIA research scientist and research associate professor in UB's Department of Psychology.

Shen said the persistent or long-lasting nature (3-6 weeks in animal models equivalent to approximately two years in humans) of this effect helps to explain why it is so difficult to abstain from

using cocaine, nicotine, amphetamine and alcohol. In addition, she added, it is a time-dependent effect that is not seen immediately after drug use, but rather manifests over a period of time following drug use and intensifies over time.

Shen and colleagues have concluded that the persistent reduction in dopamine activity parallels the long-lasting nature of addictive behaviors, including intensified craving and compulsive drug-seeking behavior. A next step is for treatment researchers to develop treatment protocols that build on this biological finding.

Source: University at Buffalo

Explore further: Dopaminergic drugs cause changes in deep brain areas of Parkinson's patient

Related Stories

Targeting brain chemistry to beat disease

November 17, 2016

Thanks to advances in big data and medicinal chemistry, scientists can screen thousands of molecules in the search for protein structures leading to new drugs for brain diseases.

Scientists identify novel compound to alleviate pain and itch

December 1, 2016

In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a possible drug candidate that suppresses pain and itch in animal models. Their new approach also reduces the potential ...

Three brain chemicals affect how we handle uncertainty

November 15, 2016

New research has revealed how three important brain signaling chemicals affect the way that we handle uncertainty. It turns out that noradrenaline regulates our estimates of how unstable the environment is, acetylcholine ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.